Drug Repurposing Study
Accelerating treatment discovery for SPATA5 & SPATA5L1
Partner: Unravel Biosciences rareSHIFT
RECRUITING: CLOSED
STATUS: FULLY-FUNDED, IN PROGRESS
APRIL 2026 UPDATE
OVERVIEW
The SPATA Foundation is partnering with Unravel Biosciences to explore new treatment opportunities through drug repurposing—an approach that identifies existing medications that may be effective for SPATA5 and SPATA5L1 disorders.
WHAT IS DRUG REPURPOSING?
Drug repurposing focuses on finding new uses for medications that are already approved or have known safety profiles. Because these drugs have already been studied in humans, this approach can significantly reduce the time, cost, and risk typically associated with developing new treatments from scratch.
OUR APPROACH
Using advanced artificial intelligence and computational biology, Unravel analyzes the underlying biology of SPATA disorders to identify drugs that may help restore cellular function. This systems-level approach allows researchers to evaluate thousands of potential options and prioritize the most promising candidates for further study.
WHY IT MATTERS
This work creates a potential path to treatment in the near term—while longer-term efforts like gene therapy continue to progress. By focusing on speed, safety, and scientific precision, drug repurposing offers real hope for improving quality of life for individuals affected by SPATA disorders.
LOOKING AHEAD
The insights gained from this study will guide future research, including laboratory validation and potential clinical opportunities. This is a critical step in building a treatment pipeline and bringing meaningful therapies closer to our community.